STAAR Surgical to Webcast Investor Presentations at American Academy of Ophthalmology's Annual Meeting Français

MONROVIA, Calif., Oct. 17, 2014 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that the Company will webcast its presentation at an Investor Breakfast Meeting on Saturday, October 18, 7:00 a.m. CT at the American Academy of Ophthalmology (AAO) Annual Meeting in Chicago, IL.

Dr. Erik Mertens, Medical Director and founder of the Medipolis Eye Centre in Antwerp, Belgium, will present his first cases with the new Preloaded ICL System.  He will also present clinical data on two years of follow up on nearly 800 Visian ICL implants with the CentraFLOW technology.  Robin Hughes, V.P. of Research and Development, will provide updates on the V6a ICL which is designed to delay the need for reading glasses as patients become of presbyopic age.

Barry G. Caldwell, STAAR's President & CEO, will offer a general overview of the Company's current operational developments and upcoming catalysts. The live audio webcast of the presentation will begin at 5:00 a.m. PT/7:00 a.m. CT/8:00 a.m. ET from the Company's website under Investor Information. The webcast will also be archived and available for 90 days following the event, also at www.staar.com.

Analysts and investors attending AAO and interested in attending the meeting in person should contact Brian Moore at [email protected] or call (310) 770-0389. 

About STAAR Surgical

STAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye and delivery systems therefor. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL." A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL." More than 450,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com. STAAR has approximately 335 full time employees and markets lenses in over 60 countries. Headquartered in Monrovia, CA, it manufactures in Aliso Viejo, CA and Monrovia, CA. For more information, please visit the Company's website at www.staar.com.

Safe Harbor

All statements in this press release that are not statements of historical fact are forward-looking statements, including statements about any of the following: any projections or performance expectations of new products or products in development, and  any financial projections.  Important additional factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in the company's Annual Report on Form 10-K for the year ended January 3, 2014, under the caption "Risk Factors," and also in the company's Quarterly Report on Form 10-Q for the period ended July 4, 2014, under the caption "Risk Factors," both of which are on file with the Securities and Exchange Commission and available in the "Investor Information" section of the company's website under the heading "SEC Filings."

These statements are based on expectations and assumptions as of the date of this press release and are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those described in the forward-looking statements.

SOURCE STAAR Surgical Company

Related Links

http://www.staar.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED